|
Aug 12
|
Revna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in Ghana
|
|
Aug 11
|
FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update
|
|
Aug 11
|
IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?
|
|
Aug 11
|
Stuttering Market Research Report 2025-2035 | AstraZeneca, via Alexion, Leads with Strensiq as the First Approved Enzyme Replacement Therapy
|
|
Aug 11
|
Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations
|
|
Aug 9
|
Solid Earnings Reflect AstraZeneca's (LON:AZN) Strength As A Business
|
|
Aug 7
|
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
|
|
Aug 7
|
Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (gMG)
|
|
Aug 7
|
RFK Jr’s mRNA funding halt signals “shift in US public health”
|
|
Aug 7
|
Inside AstraZeneca’s long-game strategy in lung cancer
|
|
Aug 6
|
Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
|
|
Aug 6
|
IonQ Announces Second Quarter Financial Results
|
|
Aug 6
|
Compugen Reports Second Quarter 2025 Results
|
|
Aug 6
|
US Health Department Ending Federal mRNA Vaccine Development
|
|
Aug 6
|
Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines
|
|
Aug 6
|
Trump says pharma tariffs to start small, then soar to 250%
|
|
Aug 5
|
Trump threatens 250pc tariffs on drug imports
|
|
Aug 5
|
EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
|
|
Aug 5
|
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
|
|
Aug 4
|
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
|